V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210032608 | 210008504 | null | 17.7 | Curative (C) | 2017-05-31 | 2017-12-04 | Methotrexate intrathecal | Y | N | 210015563 | METHOTREXATE INTRATHECAL |
| 210032609 | 210008508 | 0.96 | 88.6 | Disease modification (D) | 2016-07-13 | 2016-08-03 | Methotrexate intrathecal | N | null | 210015569 | METHOTREXATE INTRATHECAL |
| 210032610 | 210008512 | 1.79 | 12.1 | Adjuvant (A) | 2016-09-28 | 2016-10-05 | Methotrexate Intrathecal (any age) | Y | N | 210015575 | METHOTREXATE INTRATHECAL |
| 210032611 | 210008515 | 0 | 17.2 | Curative (C) | 2016-08-11 | 2017-05-09 | Methotrexate intrathecal | Y | N | 210015606 | METHOTREXATE INTRATHECAL |
| 210032612 | 210008519 | 1.82 | 37.5 | Curative (C) | 2014-01-26 | 2014-02-02 | Methotrexate intrathecal | N | N | 210015612 | METHOTREXATE INTRATHECAL |
| 210032613 | 210008523 | 0 | 14 | null | 2017-10-20 | 2017-10-20 | Methotrexate Intrathecal (any age) | N | N | 210015620 | METHOTREXATE INTRATHECAL |
| 210032614 | 210008527 | null | null | null | 2016-06-02 | 2016-07-16 | Methotrexate intrathecal | null | null | 210015630 | METHOTREXATE INTRATHECAL |
| 210032615 | 210008531 | null | 15.9 | Palliative (P) | 2014-02-08 | 2017-02-03 | Methotrexate intrathecal | N | N | 210015631 | METHOTREXATE INTRATHECAL |
| 210032616 | 210019400 | 1.55 | 11.3 | Curative (C) | 2016-09-02 | 2016-09-02 | Methotrexate Intrathecal (any age) | N | null | 210015667 | METHOTREXATE INTRATHECAL |
| 210032617 | 210008542 | 1.82 | 26.4 | Curative (C) | 2014-03-22 | 2014-04-28 | Methotrexate intrathecal | Y | N | 210015675 | METHOTREXATE INTRATHECAL |
| 210032618 | 210026436 | 1.15 | 41.2 | Disease modification (D) | 2017-07-02 | 2017-07-02 | Methotrexate intrathecal | N | N | 210015675 | METHOTREXATE INTRATHECAL |
| 210032619 | 210008550 | null | 14.5 | Curative (C) | 2017-06-05 | 2017-06-09 | Methotrexate intrathecal | N | N | 210015695 | METHOTREXATE INTRATHECAL |
| 210032620 | 210008556 | 0 | 25.1 | Disease modification (D) | 2016-01-02 | 2017-02-10 | Methotrexate intrathecal | N | N | 210015705 | METHOTREXATE INTRATHECAL |
| 210032621 | 210008561 | 1.82 | 16.1 | Neo-adjuvant (N) | 2017-10-24 | 2017-10-24 | Methotrexate Intrathecal (any age) | null | N | 210015709 | METHOTREXATE INTRATHECAL |
| 210032622 | 210008570 | 1.1 | 19.8 | null | 2013-10-31 | 2013-11-28 | Methotrexate Intrathecal (any age) | N | null | 210015714 | METHOTREXATE INTRATHECAL |
| 210032624 | 210008579 | 0 | 16.1 | Curative (C) | 2015-03-29 | 2015-06-17 | Methotrexate Intrathecal (any age) | N | N | 210015742 | METHOTREXATE INTRATHECAL |
| 210032625 | 210008583 | 0 | 79 | Curative (C) | 2014-08-09 | 2014-08-10 | Methotrexate intrathecal | 02 | null | 210015751 | METHOTREXATE INTRATHECAL |
| 210032626 | 210008588 | 1.45 | 22.5 | Adjuvant (A) | 2015-02-11 | 2015-02-18 | Methotrexate intrathecal | N | N | 210015774 | METHOTREXATE INTRATHECAL |
| 210032627 | 210008592 | 0.84 | null | Curative (C) | 2018-06-24 | 2018-07-04 | Methotrexate intrathecal | N | null | 210015782 | METHOTREXATE INTRATHECAL |
| 210032628 | 210008599 | 0 | 19.1 | Curative (C) | 2017-01-05 | 2017-05-05 | Methotrexate intrathecal | N | N | 210015788 | METHOTREXATE INTRATHECAL |
| 210032629 | 210008604 | 0 | 26.9 | Curative (C) | 2015-12-08 | 2016-01-14 | Methotrexate intrathecal | N | N | 210015793 | METHOTREXATE INTRATHECAL |
| 210032630 | 210008607 | 0 | 52.9 | Disease modification (D) | 2015-06-17 | 2015-09-02 | Methotrexate Intrathecal (any age) | Y | N | 210015802 | METHOTREXATE INTRATHECAL |
| 210032632 | 210008612 | 0 | 64.9 | Curative (C) | 2016-04-22 | 2016-11-08 | Methotrexate intrathecal | N | N | 210015816 | METHOTREXATE INTRATHECAL |
| 210032633 | 210008617 | 1.52 | 14 | Disease modification (D) | 2018-11-06 | 2018-11-07 | Methotrexate intrathecal | 2 | N | 210015820 | METHOTREXATE INTRATHECAL |
| 210032634 | 210008623 | 0.97 | 12.35 | Curative (C) | 2013-12-10 | 2014-01-16 | Methotrexate intrathecal | null | N | 210015842 | METHOTREXATE INTRATHECAL |
| 210032635 | 210008629 | 0 | 16.9 | Curative (C) | 2018-07-03 | 2018-07-08 | Methotrexate intrathecal | N | N | 210015876 | METHOTREXATE INTRATHECAL |
| 210032636 | 210008630 | 0 | 16 | Disease modification (D) | 2013-07-01 | 2013-12-03 | Methotrexate Intrathecal (any age) | Y | N | 210015880 | METHOTREXATE INTRATHECAL |
| 210032638 | 210008635 | null | 90 | Adjuvant (A) | 2018-04-26 | 2018-04-28 | Methotrexate intrathecal | 01 | N | 210015892 | METHOTREXATE INTRATHECAL |
| 210032639 | 210008636 | 0 | 0 | Curative (C) | 2016-12-27 | 2017-02-13 | Methotrexate Intrathecal (any age) | N | N | 210015897 | METHOTREXATE INTRATHECAL |
| 210032640 | 210008638 | 1.01 | null | Disease modification (D) | 2017-07-31 | 2017-10-02 | Methotrexate intrathecal | N | null | 210015904 | METHOTREXATE INTRATHECAL |
| 210032641 | 210008641 | null | 20.4 | Curative (C) | 2014-11-22 | 2015-01-02 | Methotrexate intrathecal | 02 | N | 210015905 | METHOTREXATE INTRATHECAL |
| 210032642 | 210026451 | 1.78 | 15 | Curative (C) | 2014-01-27 | 2014-02-17 | Methotrexate intrathecal | 02 | N | 210015908 | METHOTREXATE INTRATHECAL |
| 210032643 | 210026452 | 1.14 | 12.8 | Curative (C) | 2017-04-23 | 2017-04-23 | Methotrexate Intrathecal (any age) | Y | N | 210015950 | METHOTREXATE INTRATHECAL |
| 210032644 | 210008655 | null | 15.9 | Adjuvant (A) | 2016-10-09 | 2016-10-25 | Methotrexate intrathecal | N | N | 210015978 | METHOTREXATE INTRATHECAL |
| 210032645 | 210026454 | 0 | 9.76 | Disease modification (D) | 2017-10-20 | 2017-12-14 | Methotrexate Intrathecal (any age) | N | N | 210015991 | METHOTREXATE INTRATHECAL |
| 210032646 | 210026454 | 1.51 | 58.2 | null | 2017-06-09 | 2017-06-16 | Methotrexate intrathecal | N | N | 210015991 | METHOTREXATE INTRATHECAL |
| 210032647 | 210008662 | null | 15.2 | Palliative (P) | 2014-10-25 | 2014-11-09 | Methotrexate intrathecal | 02 | N | 210016020 | METHOTREXATE INTRATHECAL |
| 210032648 | 210008665 | 1.7 | 18.6 | Curative (C) | 2016-05-25 | 2016-05-25 | Methotrexate intrathecal | N | N | 210016033 | METHOTREXATE INTRATHECAL |
| 210032649 | 210008667 | 0 | 15.3 | Curative (C) | 2015-03-14 | 2015-03-21 | Methotrexate Intrathecal (any age) | Y | N | 210016060 | METHOTREXATE INTRATHECAL |
| 210032650 | 210008668 | null | 94.9 | Palliative (P) | 2015-02-13 | 2015-02-23 | Methotrexate intrathecal | null | N | 210016088 | METHOTREXATE INTRATHECAL |
| 210032651 | 210008671 | 1.7 | 57.2 | Curative (C) | 2014-06-06 | 2014-09-10 | UKALL14- Ph 2 Induction | Y | null | 210016089 | UKALL2014 |
| 210032652 | 210008674 | 1.87 | 65.8 | Curative (C) | 2016-03-08 | 2016-03-08 | UKALL14- Maintenance | Y | N | 210016120 | UKALL2014 |
| 210032653 | 210008679 | 1.83 | 68.4 | Curative (C) | 2014-10-28 | 2014-11-18 | UKALL14- Intens/CNS Proph | Y | N | 210016143 | UKALL2014 |
| 210032654 | 210008680 | 1.71 | 81.3 | Curative (C) | 2015-03-22 | 2016-08-15 | UKALL14- Intens/CNS Proph | N | N | 210016151 | UKALL2014 |
| 210032656 | 210008690 | 1.62 | 78.7 | Curative (C) | 2017-02-17 | 2017-03-03 | UKALL14- Intens/CNS Proph | Y | N | 210016176 | UKALL2014 |
| 210032657 | 210008693 | 162 | 95.3 | Curative (C) | 2012-06-26 | 2014-02-04 | UKALL14- Ph 2 Induction | Y | null | 210016177 | UKALL2014 |
| 210032658 | 210008696 | 1.73 | 71.2 | Curative (C) | null | 2015-03-04 | UKALL14- Ph 2 Induction | Y | null | 210016180 | UKALL2014 |
| 210032660 | 210008707 | 1.84 | 88 | Curative (C) | 2018-12-12 | 2019-01-23 | UKALL14- Ph 2 Induction | Y | N | 210016198 | UKALL2014 |
| 210032661 | 210008711 | 1.68 | 66.6 | Curative (C) | 2017-11-08 | 2018-06-25 | UKALL14- Intens/CNS Proph | N | N | 210016207 | UKALL2014 |
| 210032663 | 210008720 | 1.65 | 71.7 | Curative (C) | 2018-08-04 | 2018-09-12 | UKALL14- Ph 2 Induction | N | N | 210016235 | UKALL2014 |